Type 2 Diabetes Clinical Trial
Official title:
Effects Polyphenol Containing Antioxidants on Oxidative Stress in Diabetic Patients
There has been an increase in the prevalance of type 2 diabetes in developed countries in
recent years. The major contributing factors have been genetic predisposition, environmental
factors, and unhealthy eating habits and stress. Adverse effects on cardiovascular and renal
systems after prolonged hyperglycemia bring serious burden to patients, to their families
and to the society.
Oxidative stress has been defined as the imbalance between the production of reactive oxygen
molecules and antioxidant protective molecules. It has been claimed that oxidative stress
that the organism is exposed to and disturbance in anti-oxidant mechanisms have been
important in the initiation of diabetes and its complications. Malondialdehyde is the final
product of lipid peroxidation and it is an aldehyde as well. It has been accepted that
malondialdehyde has been a biomarker in measuring oxidative stress.
Type 2 diabetic people who are between 40 -65 years of age will be the subjects of our
study. The levels of fasting glucose, HbA1c, LDL, triglyceride, AST and ALT and also
malondialdehyte, hydrogen peroxide and oxidative stress will be determined in patients blood
after making them consume a 1500 calory standard diet for 2 weeks, The patients will be
randomly divided into two grouos at the end of the two weeks. Group 1 will take placebo in
addition to the diet, Group 2 will receive polyphenol containing capsules with pomegranate
extract (500 mg), green tea extract (300 mg) and a little bit of (60 mg) vitamin C for three
months. At the end of three months the measurement of biochemical parameters will be
repeated.
Patients with cardiac, renal, liver disease and smokers will be excluded from the study.
Patients in both groups will have a diet rich in vegetables, three servings of fruit,
maximum three slices of bread with a total calory of 1500.
In addition to these, both groups will have a weekly aerobic exercise regimen of 150 minutes
conducted after breakfast.
The biochemical results of the two groups will be compared at the end of the experiment and
they will be statistically evaluated.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |